NCT04593537

Brief Summary

Predicting the prognosis and treatment responses in individuals with major depressive disorder (MDD) is currently based on trial and error, because some treatments work for some individuals, but not others. Novel predictors of prognosis and treatment response in MDD can add value to the development of targeted treatments and the stratified approaches to improve long-term outcomes of individuals with MDD. This study uses a novel virtual-reality-based measure of blame-related action tendencies and combines this with established predictors of treatment response and prognosis in individuals with MDD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 13, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 20, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

February 28, 2022

Status Verified

September 1, 2020

Enrollment Period

1 year

First QC Date

October 13, 2020

Last Update Submit

February 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Self-rated Quick Inventory of Depressive Symptomatology -16

    Depressive symptoms assessed by the self-rated Quick Inventory of Depressive Symptomatology sum score. The score ranges from 0 to 27, with a higher score indicating more severe depressive symptoms.

    Four months

Secondary Outcomes (2)

  • General Anxiety Disorder-7

    Four months

  • Maudsley-Modified Patient Health Questionniare -9

    Four months

Study Arms (2)

MDD group

Participants with current major depressive disorder (MDD)

Other: No intervention

Control group

Participants without a family and personal history of a mood disorder, schizophrenia or substance/alcohol abuse but other disorders often co-morbid with MDD are allowed such as anxiety disorders

Other: No intervention

Interventions

This is an observational study, no intervention is involved

Control groupMDD group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Potential participants will be identified via online advertisements on Facebook, Google, Twitter, Instagram, self-help web groups, as well as by the IoPPN recruitment circular. Some of participants may also take part in other studies carried out by the same research team (Antidepressant Advisor studies 2 and 3) which recruit patients via online advertisements.

You may qualify if:

  • Age≥18
  • At least moderately severe major depressive syndrome on PHQ-9 (score≥15) at pre-screening despite having tried a serotonergic antidepressant medication
  • Resident in the UK
  • Able to complete self-report scales orally or in writing.
  • Age≥18
  • PHQ scores \< 10 at pre-screening
  • Resident in the UK
  • Able to complete self-report scales orally or in writing

You may not qualify if:

  • Inability to consent to the study
  • Unstable medical condition
  • Currently being treated by mental health specialist
  • Past diagnosis or family history of schizophrenia or schizo-affective disorder
  • Current or family history of psychotic symptoms or bipolar disorder.
  • Drug or alcohol abuse over the last 6 months, suspected central neurological condition (e.g. dementia, stroke)
  • (planned)Pregnancy
  • Breastfeeding or within 6 months of giving birth
  • Inability to consent to the study
  • Past history of MDD
  • First-degree family history of MDD
  • Unstable medical condition
  • Currently being treated by mental health specialist
  • Past diagnosis or family history of schizophrenia or schizo-affective disorder
  • Current or family history of psychotic symptoms or bipolar disorder.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College London, IoPPN

London, SE5 8AF, United Kingdom

Location

Related Publications (8)

  • Abramson LY, Seligman ME, Teasdale JD. Learned helplessness in humans: critique and reformulation. J Abnorm Psychol. 1978 Feb;87(1):49-74. No abstract available.

    PMID: 649856BACKGROUND
  • Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100. doi: 10.1207/s15327558ijbm0401_6.

    PMID: 16250744BACKGROUND
  • Chekroud AM, Zotti RJ, Shehzad Z, Gueorguieva R, Johnson MK, Trivedi MH, Cannon TD, Krystal JH, Corlett PR. Cross-trial prediction of treatment outcome in depression: a machine learning approach. Lancet Psychiatry. 2016 Mar;3(3):243-50. doi: 10.1016/S2215-0366(15)00471-X. Epub 2016 Jan 21.

    PMID: 26803397BACKGROUND
  • Green S, Lambon Ralph MA, Moll J, Deakin JF, Zahn R. Guilt-selective functional disconnection of anterior temporal and subgenual cortices in major depressive disorder. Arch Gen Psychiatry. 2012 Oct;69(10):1014-21. doi: 10.1001/archgenpsychiatry.2012.135.

    PMID: 22638494BACKGROUND
  • Green S, Moll J, Deakin JF, Hulleman J, Zahn R. Proneness to decreased negative emotions in major depressive disorder when blaming others rather than oneself. Psychopathology. 2013;46(1):34-44. doi: 10.1159/000338632. Epub 2012 Aug 7.

    PMID: 22890331BACKGROUND
  • Pulcu E, Zahn R, Elliott R. The role of self-blaming moral emotions in major depression and their impact on social-economical decision making. Front Psychol. 2013 Jun 3;4:310. doi: 10.3389/fpsyg.2013.00310. eCollection 2013.

    PMID: 23750148BACKGROUND
  • Tangney JP, Stuewig J, Mashek DJ. Moral emotions and moral behavior. Annu Rev Psychol. 2007;58:345-72. doi: 10.1146/annurev.psych.56.091103.070145.

    PMID: 16953797BACKGROUND
  • Zahn R, Lythe KE, Gethin JA, Green S, Deakin JF, Workman C, Moll J. Negative emotions towards others are diminished in remitted major depression. Eur Psychiatry. 2015 Jun;30(4):448-53. doi: 10.1016/j.eurpsy.2015.02.005. Epub 2015 Mar 6.

    PMID: 25752724BACKGROUND

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2020

First Posted

October 20, 2020

Study Start

June 1, 2020

Primary Completion

June 1, 2021

Study Completion

June 1, 2021

Last Updated

February 28, 2022

Record last verified: 2020-09

Locations